PERSPECTIVES ON THE DESIGN AND BIOCHEMICAL PHARMACOLOGY OF INHIBITORS OF THYMIDYLATE SYNTHETASE

被引：101

作者：

SANTI, DV ^{[1
]}

机构：

[1] UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1980年 / 23卷 / 02期

关键词：

D O I：

10.1021/jm00176a001

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：103 / 111

页数：9

共 48 条

[1]

BAKER BR, 1970, J MED CHEM, V13, P461, DOI 10.1021/jm00297a029

[2] IRREVERSIBLE ENZYME INHIBITORS .169. INHIBITION OF FUDR PHOSPHORYLASE FROM WALKER-256 RAT TUMOR BY 6-SUBSTITUTED URACILS [J].

BAKER, BR ;

KELLEY, JL .

JOURNAL OF MEDICINAL CHEMISTRY, 1970, 13 (03) :456-&

[3]

BAKER BR, 1970, J MED CHEM, V1, P87

[4]

Baker BR, 1967, DESIGN ACTIVE SITE D

[5]

BAREHAM CR, 1974, CANCER RES, V34, P571

[6]

BENNETT LL, 1975, ANTINEOPLASTIC IMM 2, P484

[7]

BERTINO JR, 1977, CANCER RES, V37, P327

[8] COMBINATION CHEMOTHERAPY AS AN ADJUVANT TREATMENT IN OPERABLE BREAST-CANCER [J].

BONADONNA, G ;

BRUSAMOLINO, E ;

VALAGUSSA, P ;

ROSSI, A ;

BRUGNATELLI, L ;

BRAMBILLA, C ;

DELENA, M ;

TANCINI, G ;

BAJETTA, E ;

MUSUMECI, R ;

VERONESI, U .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (08) :405-410

[9] URIDINE PHOSPHORYLASE, MOLECULAR-PROPERTIES AND MECHANISM OF CATALYSIS [J].

BOSE, R ;

YAMADA, EW .

BIOCHEMISTRY, 1974, 13 (10) :2051-2056

[10]

BOWEN D, 1978, CANCER RES, V38, P219

← 1 2 3 4 5 →